Skip to main content
Premium Trial:

Request an Annual Quote

Timothy Henn

Redwood City, California-based molecular diagnostics firm CardioDx has named Timothy Henn CFO. He most recently served as CFO of Crescendo Biosciences, which was acquired by Myriad Genetics in 2014. Henn has also held senior finance positions with Monogram Bioscience and Incyte.

The Scan

Rare Genetic Disease Partnership

A public-private partnership plans to speed the development of gene therapies for rare genetic diseases, Stat News writes.

Approval Sought for Alzheimer's Drug

The Wall Street Journal reports Eli Lilly has initiated a rolling submission to the US Food and Drug Administration to seek approval for its drug to treat Alzheimer's disease.

DNA Barcoding Paper Retracted

Science reports that a 2014 DNA barcoding paper was retracted after a co-author brought up data validity concerns.

Nature Papers Present Genomic Analysis of Bronze Age Mummies, Approach to Study Host-Pathogen Interactions

In Nature this week: analysis finds Tarim mummies had local genetic origin, and more.